|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,203.81 MXN | -0.28% |
|
-0.28% | -0.83% |
| 06-30 | Africa CDC seeks $18 million in urgent support for Ebola drug trials in DRC | RE |
| 06-29 | Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell 1000 Growth-Defensive Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | -0.28% | -0.28% | -0.83% | +4.94% | +58.18% | 157B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
